Sustainability & ESG Report

We create sustainable values. We live our values.

Contributing to Global Health and Well-being

Tigermed’s mission is to “Advance human health through delivery excellence”, based on which it focuses on solving the most challenging global health problems, meeting the unmet medical needs of patients, creating social value and benefiting human health.

As a pioneer in the globalization of clinical CRO in China, Tigermed has close customers and industry partners as well as a senior professional management team to constantly explore innovative solutions to meet the diverse needs of our customers and make greater contributions to pharmaceutical innovation and R&D to create social value.

  • Protecting the Environment

  • 0.28 tons

    CO2 equivalent GHG emissions per capita

    100%

    Compliance rate of waste disposal

    0

    Number of environmental safety accidents

  • Committed to Social Responsibility

  • 5.73MCNY

    Social welfare donations in 2022

    10,000copies

    Support the Clinical Research Promotion Foundation to publish the Handbook for Drug Clinical Trial Subjects and give away books in various ways

    Life Chart

    Released a public service themed microfilm in tribute to all clinical trial participants

  • Focused on Innovation

  • Innovation Pioneers

    Promote a culture of innovation and the cultivation of innovative talents

    40digital projects

    6 of the projects were awarded as outstanding innovation projects, including RBQM, DCT, E-SITE, CTMS

    Innovation Center

    Promote diversified innovation in services, operations, management and technology

  • Sustaining Employee Engagement

  • 63%

    Percentage of female employees in senior management

    89.5%

    Retention rate of key employees in domestic clinical trials

    100%

    Percentage of employees trained &
    Percentage of employees trained for business ethics

Source: 2022 Tigermed Sustainability Report and Environmental, Social and Governance Report

Tigermed’s Sustainable Development Strategies

As a leading integrated biopharmaceutical R&D service platform, Tigermed continues to support and contribute to the United Nations Sustainable Development Goals (SDGs), forging ahead with fortitude taking “Contributing to global health and well-being” as the core. While realizing our economic growth and sustainable development, the Company identify 4 key aspects of sustainable development related to our own operations and growth, and draw up corresponding strategic guidelines for the four key areas.

Report

2022 Tigermed Sustainability Report & ESG Report

2021 Tigermed Sustainability Report & ESG Report

2020 Tigermed Sustainability Report & ESG Report